New drug for recurring malaria

Share |

July 23, 2018

The medicine is specifically for the recurring form of malaria - caused by the parasite plasmodium vivax - which makes 8.5 million people ill each year.

This type of malaria is a particular challenge to get rid of as it can remain dormant in the liver for years before reawakening many times.

Scientists have described tafenoquine as a "phenomenal achievement."

Regulators around the world will now look at the drug to see if they can recommend it for their populations.

Read MORE here.

BBCE NEWS

News date : 07/23/2018    Category : Health, World News

Share |

 

Ads